Top

The International Journal of Cardiovascular Imaging

Published in:

01-01-2019 | Original Paper

Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease

Authors: Yavuz Karabağ, Ibrahim Rencuzogullari, Metin Çağdaş, Süleyman Karakoyun, Mahmut Yesin, Eray Atalay, Öznur Sadioglu Çağdaş, Mustafa Ozan Gürsoy, Cengiz Burak, Halil Ibrahim Tanboğa

Published in: The International Journal of Cardiovascular Imaging | Issue 1/2019

Abstract

Serum uric acid (SUA) level was shown in various studies to be related to the presence of coronary artery disease and subsequent cardiovascular events. The aim of the present study was to evaluate the association of SUA with SYNTAX score II (SSII) and the long-term prognosis of patients with stable angina pectoris who underwent percutaneous revascularization due to multivessel disease (MVD) and/or unprotected left main disease (UPLMD). Two-hundred and ninety patients with MVD and/or UPLMD who were treated consecutively with percutaneous coronary intervention (PCI) were included in the present study. The study population was divided into high SSII (n: 145; SSII > 32.9) and low SSII (n: 145; SSII ≤ 32.9) according to the median SSII value. The SUA value was significantly higher in the high SSII group than in the low SSII group (5.53 ± 1.95 vs. 6.07 ± 1.88; p = 0.001) and was found to be an independent predictor of high SSII (OR 1.306; 95% CI 1.119–1.525; p = 0,001). Twenty-eight patients (9.7%) died during the long-term follow-up, and SUA and SSII were additionally found to be independent predictors of long-term mortality (HR 1.245, 95% CI 1.046–1.482, p = 0.014; HR 1.042, 95% CI 1.007–1.079, p = 0.018, respectively). In the present study, SUA level was demonstrated to be associated with high SSII and long-term mortality in patients with MVD and/or UPLMD who were treated with PCI.

Kanellis J et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6):1287–1293CrossRef

Johnson RJ et al (2005) A unifying pathway for essential hypertension. Am J Hypertens 18(3):431–440CrossRef

Johnson RJ (2015) Why focus on uric acid? Curr Med Res Opin 31(suppl 2):3–7CrossRef

Libby P. Ridker PM. Maseri A (2002) Inflammation and atherosclerosis. Circulation 105(9):1135CrossRef

Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 283(18):2404–2410CrossRef

Bos MJ et al (2006) Uric acid is a risk factor for myocardial infarction and stroke. Stroke 37(6):1503–1507CrossRef

Zhu Y et al (2015) Serum cystatin C level is associated with carotid intima-media thickening and plaque. Scand J Clin Lab Invest 75(3):265–272CrossRef

Yu J et al (2014) Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease. Chin Med J 127(6):1039–1045PubMed

Sianos G et al (2005) The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 1(2):219–227PubMed

10.

Campos CM et al (2014) Predictive performance of SYNTAX Score II in patients with left main and multivessel coronary artery disease. Circ J 78(8):1942–1949CrossRef

11.

Hayiroglu MI et al (2018) Predictive value of SYNTAX score II for clinical outcomes in cardiogenic shock underwent primary percutaneous coronary intervention; a pilot study. Int J Cardiovasc Imaging 34(3):329–336CrossRef

12.

SYNTAX Score calculator (2016) http://www.syntaxscore.com. SYNTAX working-group. Accessed December 2016

13.

Farooq V et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381(9867):639–650CrossRef

14.

Piccolo R et al (2015) Stable coronary artery disease: revascularisation and invasive strategies. Lancet 386(9994):702–713CrossRef

15.

Emond M et al (1994) Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 90(6):2645–2657CrossRef

16.

Min JK et al (2007) Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 50(12):1161–1170CrossRef

17.

Vranckx P et al (2015) Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. EuroIntervention 11(2):171–179CrossRef

18.

Iwakura K et al (2003) Association between hyperglycemia and the no-reflow phenomenon inpatients with acute myocardial infarction. J Am Coll Cardiol 41(1):1–7CrossRef

19.

Hamburger JN et al (1997) Recanalization of total coronary occlusions using a laser guidewire (the European TOTAL Surveillance Study). Am J Cardiol 80(11):1419–1423CrossRef

20.

Ellis SG et al (1990) Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82(4):1193–1202CrossRef

21.

Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51(3):606CrossRef

22.

Leaman DM et al (1981) Coronary artery atherosclerosis. Circulation 63(2):285–292CrossRef

23.

Brkovic V et al (2013) Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Int J Cardiovasc Imaging 29(6):1215–1228CrossRef

24.

van Gaal WJ et al (2009) The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol 135(1):60–65CrossRef

25.

Ishizaka N et al (2007) Higher serum uric acid is associated with increased arterial stiffness in Japanese individuals. Atherosclerosis 192(1):131–137CrossRef

26.

Qureshi AE, Hameed S, Noeman A (2013) Relationship of serum uric acid level and angiographic severity of coronary artery disease in male patients with acute coronary syndrome. Pak J Med Sci 29(5):1137CrossRef

27.

Gur M et al (2008) Relation of serum uric acid levels with the presence and severity of angiographic coronary artery disease. Angiology 59(2):166–171CrossRef

28.

Wheeler JG et al (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis. PLoS Med 2(3):e76CrossRef

29.

Ekici B et al (2015) The relationship between serum uric acid levels and angiographic severity of coronary heart disease. Kardiologia Polska (Polish Heart J) 73(7):533–538CrossRef

30.

Wang B, Lin L, Zhao C (2016) Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia. Clin Exp Hypertens 38(3):312–316CrossRef

31.

Miyaoka T et al (2014) Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessel 29(4):504–512CrossRef

32.

Kocak ND et al (2016) Serum uric acid levels and uric acid/creatinine ratios in stable chronic obstructive pulmonary disease (COPD) patients: are these parameters efficient predictors of patients at risk for exacerbation and/or severity of disease? Med Sci Monit 22:4169CrossRef

33.

Sotoda Y et al (2017) Association of serum uric acid levels with leg ischemia in patients with peripheral arterial disease after treatment. J Atheroscler Thromb 24:725–734CrossRef

34.

Gonzales GF, Tapia V (2015) Increased levels of serum γ-glutamyltransferase and uric acid on metabolic, hepatic and kidney parameters in subjects at high altitudes. J Basic Clin Physiol Pharmacol 26(1):81–87PubMed

35.

Yamauchi Y et al (2017) Is serum uric acid independently associated with left ventricular mass index, ejection fraction, and B-type natriuretic peptide among female and male cardiac patients? Int Heart J 58(4):562–569CrossRef

36.

Niskanen LK et al (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Archives of internal medicine 164(14):1546–1551CrossRef

37.

Liese AD et al (1999) Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. Epidemiology 10:391–397CrossRef

Title: Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease
Authors: Yavuz Karabağ
Ibrahim Rencuzogullari
Metin Çağdaş
Süleyman Karakoyun
Mahmut Yesin
Eray Atalay
Öznur Sadioglu Çağdaş
Mustafa Ozan Gürsoy
Cengiz Burak
Halil Ibrahim Tanboğa
Publication date: 01-01-2019
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 1/2019
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-018-1446-6

2024 ASCO Annual Meeting

Springer Medicine

Association of serum uric acid levels with SYNTAX score II and long term mortality in the patients with stable angina pectoris who undergo percutaneous coronary interventions due to multivessel and/or unprotected left main disease

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2019

Left atrial mechanics in children: insights from new applications of strain imaging

Peak left atrial strain as a single measure for the non-invasive assessment of left ventricular filling pressures

Assessment of global and regional strain left ventricular in patients with preserved ejection fraction after Fontan operation using a tissue tracking technique

Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children

Abnormal aortic stiffness in patients with bicuspid aortic valve: phenotypic variation determined by magnetic resonance imaging

Prognostic importance of mechanical dyssynchrony in predicting heart failure development after ST-segment elevation myocardial infarction